• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Israeli microdosing cannabis inhaler receives approval in Canada
    April 29, 2021
    Marlboro-Maker Philip Morris Keeps Cannabis Options Open
    April 28, 2021
    Singapore-based retail analytics company Trax raises $640M Series E led by So
    April 7, 2021
    Building tech company Veev becomes the first private firm to be listed on TAS
    March 22, 2021
    Yotpo raises $230m at $1.4b valuation
    March 18, 2021
    Chemomab Completes Merger with Anchiano Therapeutics
    March 16, 2021
    Ayala Pharmaceuticals Announces $25 Million Strategic Financing
    February 19, 2021
    PolyPid Announces 100th Patient Enrolled in SHIELD I Phase 3 Clinical Trial o
    February 16, 2021
    Gamida Cell raises $75m in convertible notes
    February 16, 2021
    Hope grows for blood cancer patients, as cell therapy firm’s key trial succ
    February 11, 2021